Latest Sanofi-Aventis Stories
BOSTON, July 18, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) today announced a new research collaboration with Brigham and Women's Hospital (BWH), a teaching and research affiliate of Harvard Medical School, focused on immunology of type 1 diabetes. The two organizations will share knowledge and apply their respective expertise in basic and applied research regarding diabetes and drug target and candidate development. (Logo:...
BRIDGEWATER, N.J., July 16, 2012 /PRNewswire/ -- Sanofi US announced today that n4a Diabetes Care Center has been selected as the winner of the 2012 Data Design Diabetes(TM) Innovation Challenge (Innovation Challenge). n4a Diabetes Care Center will receive $100,000 to help match patients with certain cost patterns and risk profiles with appropriate support and services designed to slow the progression and expenditures of diabetes. To view the multimedia assets associated with this...
BRIDGEWATER, N.J., July 12, 2012 /PRNewswire/ -- Sanofi US announced today that its product MACI®( )(matrix-induced autologous chondrocyte implant) met its co-primary endpoint in a two-year, randomized, controlled clinical trial compared to microfracture, a surgical procedure designed to stimulate the growth of new cartilage. MACI uses a patient's own (autologous) cultured cartilage cells (chondrocytes) to repair articular cartilage defects in the knee joint. The results from this...
OTTAWA, July 11, 2012 /CNW/ - Health Canada has completed a thorough health risk assessment of the bladder cancer treatment ImmuCyst produced at Sanofi Pasteur's manufacturing plant in Toronto. A Health Canada inspection of Building 86 at Sanofi Pasteur's manufacturing plant in Toronto found the presence of mould in the sterile manufacturing areas where ImmuCyst was produced. Health Canada's review has concluded that ImmuCyst should remain available to bladder cancer patients,...
Parker Waichman LLP has filed a lawsuit on behalf of an Arizona woman who took Plavix (clopidogrel) and suffered from two gastrointestinal hemorrhages. The lawsuit claims that the blood thinner caused the bleeding, along with other serious and permanent injuries. (PRWEB) July 06, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging the use of Plavix caused gastrointestinal hemorrhaging in one...
NORTH GRADTON, Mass., June 28, 2012 /PRNewswire/ -- Continental Who's Who/- Mary Belmore is recognized by Continental Who's Who as a Pinnacle Professional as a result of 27 Years of Excellence in the field of Healthcare. Mary is the Associate Director of Research and Development Quality with Genzyme (a Sanofi Company). As an associate director of the Genzyme (a Sanofi Company), Ms. Belmore has been with the company for 27 years. She is responsible for overseeing the documentation...
PARSIPPANY, N.J., June 27, 2012 /PRNewswire/ -- For professionals seeking the latest in pharmaceuticals, healthcare, biotech, and devices, the hottest ticket is the Pharma CI Conference & Exhibition on September 11-12, 2012 in Parsippany, New Jersey, USA (http://pharmaciconference.com/ ). "Under the guidance of conference co-chairs representing high-level leadership at Merck and Pfizer, this event offers the very best in pharmaceutical competitive intelligence," says Amy Yueh,...
CAMPBELL, Calif., June 27, 2012 /PRNewswire/ -- DITA Exchange today announced that it has been named as a 2012 winner of Microsoft Corp.'s Life Sciences Innovation Awards. The award recognizes a DITA Exchange software solution that is helping Sanofi, a global and diversified healthcare leader, to more rapidly and efficiently produce clinical documentation deliverables with uncompromised compliance, consistency and quality. Sanofi and the ArborSys Group, a consulting services...
PARIS, June 19, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, today announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders. The collaboration was unveiled at the 2012 Bio International Convention in Boston, Mass. (LOGO: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO) Building on Joslin's...
Parker Waichman LLP has filed three lawsuits on behalf of the estates of victims who suffered fatal gastrointestinal and/or cerebral hemorrhaging allegedly due to the blood thinner, Plavix. (PRWEB) June 15, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed lawsuits alleging Bristol-Myers Squibb and Sanofi-Aventis’ Plavix caused the wrongful deaths of three patients. The suits were filed on May 30th in the...
